American Well Key Executives
This section highlights American Well's key executives, including their titles and compensation details.
Find Contacts at American Well
(Showing 0 of )
American Well Earnings
This section highlights American Well's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-12 | $-3.04 | $-2.77 |
| Read Transcript | Q3 | 2024 | 2024-10-30 | $-3.32 | $-2.87 |
| Read Transcript | Q2 | 2024 | 2024-07-31 | $-3.94 | $-3.36 |
| Read Transcript | Q1 | 2024 | 2024-05-01 | $-3.60 | $-5.00 |
| Read Transcript | Q4 | 2023 | 2024-02-14 | $-3.80 | $-3.40 |
| Read Transcript | Q3 | 2023 | 2023-11-01 | $-4.00 | $-4.00 |
| Read Transcript | Q2 | 2023 | 2023-08-02 | $-4.20 | $-4.60 |
| Read Transcript | Q1 | 2023 | 2023-05-03 | $-4.00 | $-4.80 |
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
$7.25
Stock Price
$113.17M
Market Cap
877
Employees
Boston, MA
Location
Financial Statements
Access annual & quarterly financial statements for American Well, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $254.36M | $259.05M | $277.19M | $252.79M | $245.26M |
| Cost of Revenue | $155.41M | $164.29M | $160.42M | $148.47M | $156.79M |
| Gross Profit | $98.95M | $94.76M | $116.77M | $104.31M | $88.47M |
| Gross Profit Ratio | 38.90% | 36.58% | 42.13% | 41.27% | 36.07% |
| Research and Development Expenses | $86.06M | $105.83M | $138.49M | $106.59M | $84.41M |
| General and Administrative Expenses | $121.17M | $126.64M | $146.35M | $94.62M | $166.25M |
| Selling and Marketing Expenses | $76.27M | $86.46M | $81.63M | $66.15M | $55.09M |
| Selling General and Administrative Expenses | $197.45M | $208.69M | $227.98M | $160.78M | $221.34M |
| Other Expenses | $32.98M | $472.38M | $26.15M | $16.09M | $10.15M |
| Operating Expenses | $316.49M | $786.90M | $392.62M | $283.46M | $315.91M |
| Cost and Expenses | $471.90M | $951.19M | $553.04M | $431.94M | $472.70M |
| Interest Income | $10.76M | $19.42M | $6.12M | $120.00K | $1.63M |
| Interest Expense | $- | $- | $6.12M | $120.00K | $1.63M |
| Depreciation and Amortization | $32.98M | $31.92M | $26.77M | $16.83M | $11.01M |
| EBITDA | $-184.56M | $-225.99M | $-249.69M | $-162.20M | $-216.93M |
| EBITDA Ratio | -72.56% | -87.24% | -90.08% | -64.16% | -88.45% |
| Operating Income | $-217.53M | $-692.14M | $-275.85M | $-179.15M | $-227.43M |
| Operating Income Ratio | -85.52% | -267.19% | -99.52% | -70.87% | -92.73% |
| Total Other Income Expenses Net | $10.76M | $19.42M | $6.12M | $120.00K | $1.63M |
| Income Before Tax | $-206.78M | $-672.72M | $-269.73M | $-179.03M | $-225.80M |
| Income Before Tax Ratio | -81.29% | -259.69% | -97.31% | -70.82% | -92.06% |
| Income Tax Expense | $2.75M | $3.86M | $64.00K | $-5.38M | $639.00K |
| Net Income | $-208.14M | $-675.16M | $-269.79M | $-173.65M | $-226.44M |
| Net Income Ratio | -81.83% | -260.63% | -97.33% | -68.69% | -92.32% |
| EPS | $-13.88 | $-47.50 | $-19.68 | $-13.67 | $-45.72 |
| EPS Diluted | $-13.88 | $-47.50 | $-19.68 | $-13.67 | $-45.72 |
| Weighted Average Shares Outstanding | 15.00M | 14.21M | 13.71M | 12.70M | 4.95M |
| Weighted Average Shares Outstanding Diluted | 15.00M | 14.21M | 13.71M | 12.70M | 4.95M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.01M | $61.05M | $62.79M | $59.52M | $70.68M | $61.92M | $62.45M | $64.00M | $79.23M | $69.21M | $64.52M | $64.23M | $72.75M | $62.22M | $60.22M | $57.60M | $60.43M | $62.55M | $68.57M | $53.71M |
| Cost of Revenue | $36.61M | $38.35M | $39.29M | $49.39M | $55.10M | $40.46M | $38.24M | $38.75M | $45.65M | $41.51M | $36.50M | $36.77M | $43.70M | $35.18M | $33.89M | $35.70M | $37.82M | $42.12M | $43.83M | $33.03M |
| Gross Profit | $34.39M | $22.69M | $23.50M | $10.13M | $15.58M | $21.46M | $24.20M | $25.25M | $33.58M | $27.70M | $28.02M | $27.47M | $29.05M | $27.04M | $26.33M | $21.89M | $22.61M | $20.43M | $24.74M | $20.69M |
| Gross Profit Ratio | 48.44% | 37.18% | 37.42% | 17.02% | 22.04% | 34.66% | 38.76% | 39.45% | 42.38% | 40.03% | 43.43% | 42.76% | 39.94% | 43.45% | 43.72% | 38.01% | 37.42% | 32.67% | 36.08% | 38.51% |
| Research and Development Expenses | $18.78M | $19.80M | $20.81M | $26.68M | $26.35M | $27.71M | $25.84M | $25.92M | $27.68M | $36.25M | $37.07M | $37.48M | $33.78M | $27.40M | $22.38M | $23.04M | $26.56M | $25.27M | $17.64M | $14.94M |
| General and Administrative Expenses | $34.77M | $25.18M | $28.46M | $32.76M | $24.39M | $29.57M | $36.32M | $36.37M | $41.04M | $37.68M | $34.91M | $32.72M | $14.68M | $34.38M | $24.21M | $21.35M | $27.71M | $43.11M | $80.08M | $15.34M |
| Selling and Marketing Expenses | $15.39M | $16.77M | $18.39M | $25.73M | $21.80M | $20.38M | $21.55M | $22.73M | $23.26M | $18.49M | $18.72M | $21.15M | $21.26M | $16.37M | $14.79M | $13.73M | $15.12M | $13.76M | $12.35M | $13.87M |
| Selling General and Administrative Expenses | $50.16M | $41.95M | $46.85M | $49.82M | $45.11M | $49.95M | $57.87M | $59.10M | $64.30M | $56.17M | $53.63M | $53.87M | $35.94M | $50.75M | $39.00M | $35.09M | $42.83M | $56.87M | $92.43M | $29.22M |
| Other Expenses | $8.21M | $8.31M | $8.22M | $8.24M | $8.27M | $87.16M | $34.99M | $7.24M | $6.43M | $6.40M | $6.72M | $6.60M | $6.76M | $4.34M | $2.48M | $2.51M | $2.78M | $2.58M | $2.51M | $2.29M |
| Operating Expenses | $77.15M | $70.06M | $75.87M | $76.50M | $71.46M | $85.93M | $91.43M | $92.26M | $98.42M | $98.83M | $97.42M | $97.95M | $76.48M | $82.49M | $63.86M | $60.63M | $72.17M | $84.72M | $112.57M | $46.44M |
| Cost and Expenses | $113.76M | $108.42M | $115.17M | $125.89M | $126.56M | $126.39M | $129.68M | $131.01M | $144.08M | $140.33M | $133.92M | $134.71M | $120.17M | $117.67M | $97.75M | $96.34M | $109.99M | $126.84M | $156.40M | $79.47M |
| Interest Income | $423.00K | $3.88M | $2.67M | $3.78M | $8.17M | $7.98M | $2.33M | $940.00K | $4.01M | $1.24M | $764.00K | $108.00K | $217.00K | $- | $224.00K | $61.00K | $222.00K | $255.00K | $308.00K | $847.00K |
| Interest Expense | $- | $- | $2.67M | $3.78M | $8.17M | $7.98M | $2.33M | $108.00K | $4.01M | $1.24M | $764.00K | $108.00K | $217.00K | $382.00K | $224.00K | $61.00K | $222.00K | $255.00K | $308.00K | $847.00K |
| Depreciation and Amortization | $8.21M | $8.31M | $8.22M | $8.32M | $8.37M | $8.37M | $7.83M | $7.35M | $6.60M | $6.56M | $6.88M | $6.73M | $6.96M | $5.24M | $2.66M | $2.68M | $2.78M | $2.58M | $2.51M | $2.29M |
| EBITDA | $-34.55M | $-39.06M | $-44.16M | $-66.80M | $-50.50M | $-56.20M | $-59.52M | $-59.77M | $-58.22M | $-64.54M | $-62.12M | $-63.64M | $-40.24M | $-50.59M | $-35.05M | $-36.23M | $-46.56M | $-61.71M | $-85.32M | $-23.46M |
| EBITDA Ratio | -48.66% | -63.98% | -70.33% | -112.22% | -71.45% | -90.76% | -95.32% | -93.39% | -73.48% | -93.25% | -96.28% | -99.08% | -55.32% | -81.30% | -58.21% | -62.90% | -77.04% | -98.66% | -124.44% | -43.69% |
| Operating Income | $-42.76M | $-47.37M | $-52.38M | $-66.37M | $-55.88M | $-143.36M | $-94.51M | $263.30M | $-64.84M | $-71.12M | $-69.40M | $-70.48M | $-47.42M | $-55.45M | $-37.53M | $-38.74M | $-49.56M | $-64.29M | $-87.83M | $-25.75M |
| Operating Income Ratio | -60.21% | -77.60% | -83.41% | -111.51% | -79.07% | -231.52% | -151.34% | 411.40% | -81.84% | -102.77% | -107.58% | -109.73% | -65.19% | -89.11% | -62.33% | -67.25% | -82.01% | -102.78% | -128.09% | -47.94% |
| Total Other Income Expenses Net | $423.00K | $3.88M | $2.67M | $3.78M | $8.17M | $7.98M | $2.33M | $940.00K | $4.01M | $1.24M | $764.00K | $108.00K | $217.00K | $-382.00K | $224.00K | $61.00K | $222.00K | $255.00K | $308.00K | $847.00K |
| Income Before Tax | $-42.33M | $-43.49M | $-49.71M | $-71.25M | $-48.78M | $-135.38M | $-92.17M | $-396.38M | $-60.83M | $-69.89M | $-68.64M | $-70.37M | $-47.21M | $-55.83M | $-37.31M | $-38.68M | $-49.34M | $-64.03M | $-87.52M | $-24.90M |
| Income Before Tax Ratio | -59.62% | -71.24% | -79.17% | -119.70% | -69.02% | -218.63% | -147.60% | -619.34% | -76.77% | -100.98% | -106.39% | -109.56% | -64.89% | -89.73% | -61.96% | -67.15% | -81.64% | -102.37% | -127.65% | -46.36% |
| Income Tax Expense | $1.53M | $-149.00K | $-97.00K | $1.27M | $547.00K | $1.12M | $716.00K | $1.48M | $-160.00K | $95.00K | $461.00K | $-332.00K | $-334.00K | $-5.45M | $103.00K | $309.00K | $309.00K | $78.00K | $252.00K | $-523.00K |
| Net Income | $-42.65M | $-43.46M | $-49.92M | $-72.11M | $-48.59M | $-136.41M | $-92.47M | $-397.86M | $-60.67M | $-69.98M | $-69.10M | $-70.04M | $-47.79M | $-51.49M | $-37.86M | $-39.19M | $-50.31M | $-63.08M | $-86.66M | $-24.38M |
| Net Income Ratio | -60.07% | -71.20% | -79.50% | -121.14% | -68.75% | -220.30% | -148.09% | -621.64% | -76.57% | -101.12% | -107.11% | -109.05% | -65.69% | -82.76% | -62.87% | -68.04% | -83.25% | -100.85% | -126.38% | -45.39% |
| EPS | $-2.77 | $-2.87 | $-3.36 | $-4.94 | $-3.37 | $-9.54 | $-6.53 | $-28.42 | $-4.36 | $-5.05 | $-5.06 | $-5.23 | $-3.59 | $-4.00 | $-3.04 | $-3.22 | $-4.16 | $-18.42 | $-39.86 | $-11.51 |
| EPS Diluted | $-2.77 | $-2.87 | $-3.36 | $-4.94 | $-3.37 | $-9.54 | $-6.53 | $-28.42 | $-4.36 | $-5.05 | $-5.06 | $-5.23 | $-3.59 | $-4.00 | $-3.04 | $-3.22 | $-4.16 | $-18.42 | $-39.86 | $-11.51 |
| Weighted Average Shares Outstanding | 15.40M | 15.14M | 14.86M | 14.59M | 14.40M | 14.30M | 14.15M | 14.00M | 13.92M | 13.87M | 13.67M | 13.40M | 13.30M | 12.86M | 12.47M | 12.18M | 12.08M | 3.42M | 2.17M | 2.12M |
| Weighted Average Shares Outstanding Diluted | 15.40M | 15.14M | 14.88M | 14.59M | 14.40M | 14.30M | 14.15M | 14.00M | 13.92M | 13.87M | 13.67M | 13.40M | 13.30M | 12.86M | 12.47M | 12.18M | 12.08M | 3.42M | 2.17M | 2.12M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $228.32M | $372.04M | $538.55M | $746.42M | $941.62M |
| Short Term Investments | $- | $- | $- | $- | $99.96M |
| Cash and Short Term Investments | $228.32M | $372.04M | $538.55M | $746.42M | $1.04B |
| Net Receivables | $71.89M | $54.15M | $58.37M | $51.38M | $45.30M |
| Inventory | $2.86M | $6.65M | $8.74M | $7.53M | $9.13M |
| Other Current Assets | $13.93M | $16.75M | $40.53M | $21.98M | $17.28M |
| Total Current Assets | $316.99M | $449.58M | $626.62M | $827.30M | $1.11B |
| Property Plant Equipment Net | $7.58M | $11.03M | $14.52M | $18.66M | $10.45M |
| Goodwill | $- | $- | $435.28M | $442.76M | $193.88M |
| Intangible Assets | $101.54M | $120.25M | $134.98M | $152.41M | $55.53M |
| Goodwill and Intangible Assets | $101.54M | $120.25M | $570.26M | $595.17M | $249.41M |
| Long Term Investments | $1.50M | $1.18M | $795.00K | $168.00K | $752.00K |
| Tax Assets | $- | $- | $-795.00K | $2.03M | $1.33M |
| Other Non-Current Assets | $8.36M | $7.67M | $6.16M | $2.52M | $1.43M |
| Total Non-Current Assets | $118.97M | $140.12M | $590.94M | $618.54M | $263.36M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $435.97M | $589.71M | $1.22B | $1.45B | $1.38B |
| Account Payables | $5.01M | $4.86M | $7.24M | $12.16M | $5.80M |
| Short Term Debt | $3.69M | $7.88M | $6.11M | $3.84M | $12.71M |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $53.23M | $46.37M | $49.51M | $68.84M | $66.69M |
| Other Current Liabilities | $49.33M | $38.99M | $51.20M | $56.79M | $35.78M |
| Total Current Liabilities | $111.26M | $93.80M | $114.06M | $141.63M | $120.98M |
| Long Term Debt | $4.51M | $8.21M | $11.79M | $14.69M | $1.30M |
| Deferred Revenue Non-Current | $- | $6.09M | $6.29M | $7.05M | $8.11M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $3.95M | $1.43M | $1.57M | $21.59M | $64.00K |
| Total Non-Current Liabilities | $8.46M | $15.72M | $19.65M | $43.34M | $9.47M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $119.72M | $109.52M | $133.71M | $184.96M | $130.45M |
| Preferred Stock | $- | $- | $- | $- | $1.38B |
| Common Stock | $156.00K | $2.88M | $2.77M | $2.62M | $2.36M |
| Retained Earnings | $-1.97B | $-1.76B | $-1.08B | $-811.28M | $-582.36M |
| Accumulated Other Comprehensive Income Loss | $-15.84M | $-15.65M | $-16.97M | $-6.35M | $297.00K |
| Other Total Stockholders Equity | $2.29B | $2.23B | $2.16B | $2.05B | $1.80B |
| Total Stockholders Equity | $304.77M | $464.22M | $1.06B | $1.24B | $1.22B |
| Total Equity | $316.24M | $480.19M | $1.08B | $1.26B | $1.25B |
| Total Liabilities and Stockholders Equity | $435.97M | $589.71M | $1.22B | $1.45B | $1.38B |
| Minority Interest | $11.47M | $15.97M | $19.97M | $21.62M | $22.07M |
| Total Liabilities and Total Equity | $435.97M | $589.71M | $1.22B | $1.45B | $1.38B |
| Total Investments | $1.50M | $1.18M | $795.00K | $168.00K | $100.72M |
| Total Debt | $8.20M | $11.79M | $14.84M | $16.61M | $7.65M |
| Net Debt | $-220.12M | $-360.25M | $-523.70M | $-729.80M | $-933.96M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $228.32M | $244.65M | $276.91M | $308.60M | $372.04M | $319.37M | $161.36M | $112.89M | $538.55M | $332.60M | $257.19M | $176.93M | $746.42M | $790.40M | $975.19M | $896.38M | $941.62M | $956.42M | $232.69M | $123.83M |
| Short Term Investments | $- | $795.00K | $- | $- | $- | $98.72M | $297.33M | $394.31M | $- | $249.01M | $372.88M | $497.97M | $- | $- | $- | $100.00M | $99.96M | $129.91M | $30.00M | $29.99M |
| Cash and Short Term Investments | $228.32M | $244.65M | $276.91M | $308.60M | $372.04M | $418.09M | $458.68M | $507.20M | $538.55M | $581.61M | $630.07M | $674.91M | $746.42M | $790.40M | $975.19M | $996.38M | $1.04B | $1.09B | $262.69M | $153.82M |
| Net Receivables | $71.89M | $89.26M | $76.09M | $80.71M | $54.15M | $46.71M | $48.40M | $55.87M | $58.37M | $45.73M | $44.67M | $47.15M | $51.38M | $39.85M | $35.54M | $37.68M | $45.30M | $39.96M | $40.80M | $34.27M |
| Inventory | $2.86M | $4.76M | $5.57M | $6.58M | $6.65M | $7.83M | $8.53M | $8.44M | $8.74M | $7.97M | $7.92M | $8.03M | $7.53M | $9.10M | $8.93M | $9.37M | $9.13M | $7.78M | $5.21M | $3.72M |
| Other Current Assets | $13.93M | $18.20M | $36.88M | $32.02M | $31.23M | $16.20M | $19.83M | $16.75M | $40.53M | $21.94M | $23.93M | $23.07M | $21.98M | $15.24M | $16.74M | $17.88M | $17.28M | $9.57M | $13.02M | $12.58M |
| Total Current Assets | $316.99M | $356.88M | $375.85M | $411.90M | $447.32M | $488.84M | $535.44M | $588.25M | $626.62M | $657.24M | $706.59M | $753.15M | $827.30M | $854.59M | $1.04B | $1.06B | $1.11B | $1.14B | $321.72M | $204.39M |
| Property Plant Equipment Net | $7.58M | $8.44M | $9.30M | $10.18M | $11.03M | $11.82M | $12.36M | $13.33M | $14.52M | $15.49M | $16.01M | $17.34M | $18.66M | $20.49M | $6.47M | $8.38M | $10.45M | $12.55M | $13.51M | $13.94M |
| Goodwill | $- | $- | $- | $- | $- | $- | $79.42M | $106.71M | $435.28M | $425.20M | $433.84M | $440.70M | $442.76M | $443.90M | $193.88M | $193.88M | $193.88M | $193.88M | $193.88M | $193.88M |
| Intangible Assets | $101.54M | $108.88M | $111.22M | $114.34M | $120.25M | $125.89M | $134.95M | $135.40M | $134.98M | $127.29M | $136.43M | $145.35M | $152.41M | $159.93M | $51.67M | $53.60M | $55.53M | $57.72M | $59.66M | $61.60M |
| Goodwill and Intangible Assets | $101.54M | $108.88M | $111.22M | $114.34M | $120.25M | $125.89M | $214.37M | $242.11M | $570.26M | $552.49M | $570.27M | $586.04M | $595.17M | $603.83M | $245.55M | $247.48M | $249.41M | $251.59M | $253.53M | $255.47M |
| Long Term Investments | $1.50M | $493.00K | $1.99M | $2.76M | $1.98M | $1.89M | $2.49M | $178.00K | $795.00K | $773.00K | $1.37M | $795.00K | $168.00K | $1.21M | $1.76M | $2.48M | $752.00K | $1.69M | $2.18M | $2.62M |
| Tax Assets | $- | $2.39M | $-1 | $- | $- | $3.60M | $4.52M | $- | $-795.00K | $- | $- | $-795.00K | $2.03M | $1.92M | $898.00K | $1.12M | $1.33M | $2.63M | $2.53M | $- |
| Other Non-Current Assets | $8.36M | $10.70M | $9.46M | $9.20M | $9.14M | $2.96M | $2.99M | $6.64M | $6.16M | $5.78M | $4.23M | $4.47M | $2.52M | $2.31M | $1.25M | $1.39M | $1.43M | $1.92M | $2.93M | $4.47M |
| Total Non-Current Assets | $118.97M | $128.50M | $131.98M | $136.49M | $142.38M | $146.16M | $236.74M | $262.25M | $590.94M | $574.53M | $591.88M | $608.65M | $618.54M | $629.76M | $255.92M | $260.86M | $263.36M | $270.39M | $274.68M | $276.51M |
| Other Assets | $- | $-2.39M | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-0 | $- | $- | $- | $- |
| Total Assets | $435.97M | $482.99M | $507.82M | $548.38M | $589.71M | $635.00M | $772.18M | $850.50M | $1.22B | $1.23B | $1.30B | $1.36B | $1.45B | $1.48B | $1.29B | $1.32B | $1.38B | $1.41B | $596.40M | $480.90M |
| Account Payables | $5.01M | $8.15M | $5.92M | $6.71M | $4.86M | $4.82M | $4.52M | $7.05M | $7.24M | $6.17M | $5.49M | $7.50M | $12.16M | $5.28M | $5.17M | $6.80M | $5.80M | $7.67M | $4.46M | $6.46M |
| Short Term Debt | $3.69M | $7.32M | $7.25M | $3.60M | $7.16M | $6.80M | $5.86M | $3.01M | $6.11M | $7.25M | $6.35M | $5.33M | $3.84M | $6.24M | $6.94M | $9.86M | $12.71M | $12.64M | $6.16M | $6.19M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $53.23M | $62.46M | $64.27M | $59.08M | $46.37M | $53.08M | $60.21M | $65.61M | $49.51M | $50.15M | $63.97M | $68.84M | $68.84M | $60.95M | $57.84M | $63.20M | $66.69M | $54.32M | $62.02M | $- |
| Other Current Liabilities | $49.33M | $44.25M | $40.46M | $39.03M | $35.41M | $33.98M | $39.65M | $39.92M | $51.20M | $41.56M | $40.48M | $47.12M | $56.79M | $54.64M | $21.39M | $18.45M | $35.78M | $31.98M | $90.04M | $87.11M |
| Total Current Liabilities | $111.26M | $122.17M | $117.90M | $108.43M | $93.80M | $98.68M | $110.25M | $115.59M | $114.06M | $105.13M | $116.28M | $128.79M | $141.63M | $127.11M | $91.34M | $98.32M | $120.98M | $106.62M | $100.66M | $99.76M |
| Long Term Debt | $4.51M | $5.44M | $6.36M | $7.29M | $8.21M | $9.09M | $9.99M | $10.85M | $11.79M | $12.21M | $12.84M | $13.72M | $14.69M | $14.99M | $776.00K | $970.00K | $1.30M | $3.06M | $4.04M | $5.65M |
| Deferred Revenue Non-Current | $2.78M | $3.82M | $4.28M | $7.89M | $6.09M | $5.95M | $6.60M | $8.18M | $6.29M | $6.91M | $4.78M | $5.99M | $7.05M | $7.05M | $7.53M | $7.46M | $8.11M | $7.48M | $9.92M | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $-4.28M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $1.17M | $1.50M | $1.42M | $1.41M | $1.43M | $1.59M | $1.65M | $1.61M | $1.57M | $2.67M | $3.68M | $4.52M | $21.59M | $37.55M | $26.00K | $45.00K | $64.00K | $115.00K | $10.03M | $55.00K |
| Total Non-Current Liabilities | $8.46M | $10.76M | $12.05M | $16.60M | $15.72M | $16.63M | $18.24M | $20.64M | $19.65M | $21.80M | $21.30M | $24.22M | $43.34M | $59.59M | $8.33M | $8.47M | $9.47M | $10.65M | $14.07M | $14.60M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $119.72M | $132.94M | $129.95M | $125.03M | $109.52M | $115.31M | $128.49M | $136.23M | $133.71M | $126.92M | $137.58M | $153.01M | $184.96M | $186.70M | $99.68M | $106.79M | $130.45M | $117.27M | $114.73M | $114.37M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1.29B | $1.32B | $- | $1.41B | $801.81M | $668.29M |
| Common Stock | $156.00K | $153.00K | $151.00K | $2.96M | $2.88M | $2.86M | $2.83M | $2.80M | $2.77M | $2.75M | $2.73M | $2.66M | $2.62M | $2.60M | $2.42M | $2.40M | $2.36M | $2.34M | $1.80M | $50.00K |
| Retained Earnings | $-1.97B | $-1.92B | $-1.88B | $-1.83B | $-1.76B | $-1.71B | $-1.57B | $-1.48B | $-1.08B | $-1.02B | $-950.47M | $-881.32M | $-811.28M | $-762.44M | $-708.59M | $-668.87M | $-582.36M | $-532.05M | $-492.61M | $-382.31M |
| Accumulated Other Comprehensive Income Loss | $-15.84M | $-15.77M | $-20.96M | $-16.21M | $-15.65M | $-13.55M | $-8.87M | $-10.59M | $-16.97M | $-31.06M | $-20.84M | $-10.55M | $-6.35M | $-2.24M | $140.00K | $279.00K | $297.00K | $50.00K | $148.00K | $122.00K |
| Other Total Stockholders Equity | $2.29B | $2.28B | $2.26B | $2.25B | $2.23B | $2.22B | $2.20B | $2.18B | $2.16B | $2.13B | $2.11B | $2.08B | $2.05B | $2.04B | $1.88B | $1.86B | $1.80B | $1.80B | $950.23M | $54.96M |
| Total Stockholders Equity | $304.77M | $336.66M | $363.90M | $408.74M | $464.22M | $502.27M | $625.58M | $695.12M | $1.06B | $1.08B | $1.14B | $1.19B | $1.24B | $1.28B | $1.17B | $1.19B | $1.22B | $1.27B | $457.81M | $341.12M |
| Total Equity | $316.24M | $350.05M | $377.87M | $423.36M | $480.19M | $519.70M | $643.69M | $714.28M | $1.08B | $1.10B | $1.16B | $1.21B | $1.26B | $1.30B | $1.19B | $1.22B | $1.25B | $1.30B | $481.67M | $366.53M |
| Total Liabilities and Stockholders Equity | $435.97M | $482.99M | $507.82M | $548.38M | $589.71M | $635.00M | $772.18M | $850.50M | $1.22B | $1.23B | $1.30B | $1.36B | $1.45B | $1.48B | $1.29B | $1.32B | $1.38B | $1.41B | $596.40M | $480.90M |
| Minority Interest | $11.47M | $13.39M | $13.96M | $14.62M | $15.97M | $17.42M | $18.11M | $19.15M | $19.97M | $20.40M | $20.89M | $21.40M | $21.62M | $21.73M | $21.17M | $21.45M | $22.07M | $22.34M | $23.85M | $25.42M |
| Total Liabilities and Total Equity | $435.97M | $482.99M | $507.82M | $548.38M | $589.71M | $635.00M | $772.18M | $850.50M | $1.22B | $1.23B | $1.30B | $1.36B | $1.45B | $1.48B | $1.29B | $1.32B | $1.38B | $1.41B | $596.40M | $480.90M |
| Total Investments | $1.50M | $1.29M | $1.99M | $2.76M | $1.98M | $100.61M | $299.82M | $394.49M | $795.00K | $249.78M | $374.25M | $497.97M | $168.00K | $1.21M | $1.76M | $102.48M | $100.72M | $131.60M | $32.17M | $32.61M |
| Total Debt | $8.20M | $9.10M | $9.99M | $10.89M | $11.79M | $12.49M | $12.93M | $13.86M | $14.84M | $15.83M | $16.02M | $16.38M | $16.61M | $18.11M | $4.25M | $5.90M | $7.65M | $9.38M | $10.20M | $5.65M |
| Net Debt | $-220.12M | $-235.55M | $-266.92M | $-297.70M | $-360.25M | $-306.88M | $-148.43M | $-99.03M | $-523.70M | $-316.77M | $-241.17M | $-160.55M | $-729.80M | $-772.29M | $-970.94M | $-890.48M | $-933.96M | $-947.04M | $-222.50M | $-118.19M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $- | $-675.16M | $-272.07M | $-176.78M | $-228.63M |
| Depreciation and Amortization | $- | $31.92M | $26.17M | $16.09M | $10.15M |
| Deferred Income Tax | $-243.00K | $-242.00K | $-2.52M | $-6.25M | $3.83M |
| Stock Based Compensation | $- | $72.25M | $67.67M | $43.81M | $118.36M |
| Change in Working Capital | $- | $-15.51M | $-28.10M | $-27.71M | $-18.45M |
| Accounts Receivables | $- | $3.25M | $-8.14M | $-512.00K | $-14.21M |
| Inventory | $- | $2.08M | $-1.21M | $1.60M | $-6.02M |
| Accounts Payables | $- | $-2.36M | $-4.78M | $5.55M | $-707.00K |
| Other Working Capital | $- | $-18.48M | $-13.97M | $-34.35M | $2.50M |
| Other Non Cash Items | $-127.09M | $438.40M | $16.53M | $9.31M | $2.26M |
| Net Cash Provided by Operating Activities | $-127.34M | $-148.34M | $-192.32M | $-141.54M | $-112.46M |
| Investments in Property Plant and Equipment | $- | $-292.00K | $-10.45M | $-559.00K | $-3.32M |
| Acquisitions Net | $- | $- | $-1.96M | $-159.07M | $-2.94M |
| Purchases of Investments | $- | $-389.99M | $-499.22M | $2.55M | $-159.61M |
| Sales Maturities of Investments | $- | $389.99M | $500.00M | $100.00M | $99.11M |
| Other Investing Activities | $-18.65M | $-18.88M | $-11.34M | $-2.55M | $-63.44M |
| Net Cash Used for Investing Activities | $-18.65M | $-19.17M | $-11.63M | $-59.63M | $-66.76M |
| Debt Repayment | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $- | $- | $- | $872.03M |
| Common Stock Repurchased | $-3.00K | $-586.00K | $-360.00K | $-15.04M | $-37.57M |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $1.38M | $2.73M | $-3.25M | $20.79M | $148.65M |
| Net Cash Used Provided by Financing Activities | $1.38M | $2.15M | $-3.61M | $5.75M | $983.12M |
| Effect of Forex Changes on Cash | $887.00K | $-1.14M | $-305.00K | $-84.00K | $- |
| Net Change in Cash | $-143.72M | $-166.51M | $-207.87M | $-195.50M | $803.89M |
| Cash at End of Period | $229.11M | $372.83M | $539.34M | $747.21M | $942.71M |
| Cash at Beginning of Period | $372.83M | $539.34M | $747.21M | $942.71M | $138.82M |
| Operating Cash Flow | $-127.34M | $-148.34M | $-192.32M | $-141.54M | $-112.46M |
| Capital Expenditure | $- | $-15.25M | $-10.45M | $-559.00K | $-3.32M |
| Free Cash Flow | $-127.34M | $-163.59M | $-202.77M | $-142.10M | $-115.78M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-44.57M | $-44.04M | $-49.92M | $-72.11M | $-48.59M | $-137.10M | $-93.52M | $-398.51M | $-61.59M | $-70.58M | $-69.65M | $-70.25M | $-47.91M | $-50.93M | $-38.14M | $-39.80M | $-50.59M | $-64.60M | $-88.22M | $-25.22M |
| Depreciation and Amortization | $8.21M | $8.14M | $8.30M | $8.32M | $8.37M | $8.27M | $7.71M | $7.24M | $6.62M | $6.41M | $6.53M | $6.60M | $6.76M | $4.34M | $2.48M | $2.51M | $2.78M | $2.58M | $2.51M | $2.29M |
| Deferred Income Tax | $-245.00K | $13.00K | $-6.00K | $-5.00K | $-218.00K | $-1.00K | $-10.00K | $-13.00K | $-1.13M | $-226.00K | $-721.00K | $-443.00K | $-2.06M | $-5.45M | $405.00K | $1.08M | $1.35M | $-470.00K | $919.00K | $485.00K |
| Stock Based Compensation | $10.88M | $10.60M | $9.82M | $16.24M | $12.68M | $16.88M | $21.68M | $21.01M | $19.26M | $20.82M | $15.52M | $12.07M | $11.34M | $13.11M | $10.73M | $8.64M | $11.84M | $34.42M | $67.64M | $4.46M |
| Change in Working Capital | $2.63M | $-8.92M | $9.57M | $-13.26M | $-14.73M | $-6.26M | $-3.89M | $9.38M | $-6.54M | $-10.91M | $2.09M | $-12.73M | $-17.47M | $6.13M | $-2.30M | $-14.07M | $9.18M | $-3.89M | $-9.21M | $-14.54M |
| Accounts Receivables | $10.92M | $-13.24M | $4.81M | $-27.51M | $-8.23M | $1.31M | $7.82M | $2.34M | $-12.94M | $-967.00K | $1.47M | $4.29M | $-11.84M | $1.52M | $2.45M | $7.36M | $-5.74M | $240.00K | $-7.00M | $-1.71M |
| Inventory | $10.00K | $812.00K | $1.00M | $74.00K | $1.18M | $700.00K | $-94.00K | $299.00K | $-768.00K | $-48.00K | $104.00K | $-495.00K | $1.57M | $-171.00K | $437.00K | $-238.00K | $-1.35M | $-2.56M | $-1.50M | $-612.00K |
| Accounts Payables | $-3.15M | $2.23M | $-779.00K | $1.85M | $-4.00K | $396.00K | $-2.51M | $-247.00K | $1.02M | $728.00K | $-1.92M | $-4.60M | $6.88M | $-708.00K | $-1.65M | $1.02M | $-572.00K | $2.36M | $-2.45M | $-45.00K |
| Other Working Capital | $-5.16M | $1.27M | $4.53M | $12.33M | $-7.68M | $-8.67M | $-9.12M | $6.99M | $6.15M | $-10.63M | $2.43M | $-11.92M | $-14.08M | $5.49M | $-3.55M | $-22.21M | $16.85M | $-3.92M | $1.74M | $-12.17M |
| Other Non Cash Items | $9.66M | $1.86M | $21.83M | $59.51M | $907.00K | $80.23M | $28.41M | $331.74M | $7.44M | $3.51M | $3.02M | $2.56M | $4.42M | $3.59M | $574.00K | $508.00K | $900.00K | $1.84M | $630.00K | $439.00K |
| Net Cash Provided by Operating Activities | $-13.44M | $-32.35M | $-21.79M | $-59.76M | $-41.58M | $-37.99M | $-39.63M | $-29.15M | $-35.95M | $-50.98M | $-43.21M | $-62.19M | $-44.92M | $-29.22M | $-26.25M | $-41.14M | $-24.53M | $-30.11M | $-25.73M | $-32.09M |
| Investments in Property Plant and Equipment | $-3.00K | $-15.00K | $-5.18M | $-2.89M | $-1.32M | $-60.00K | $-7.10M | $-6.77M | $-10.45M | $56.00K | $10.00K | $-68.00K | $-338.00K | $62.00K | $-135.00K | $-148.00K | $-57.00K | $-957.00K | $-1.05M | $-1.25M |
| Acquisitions Net | $-1.72M | $- | $- | $-1.72M | $3.92M | $- | $-2.94M | $-980.00K | $1.96M | $- | $-1.96M | $- | $2.55M | $-156.53M | $- | $-2.55M | $2.94M | $- | $- | $-2.94M |
| Purchases of Investments | $- | $- | $- | $-1.72M | $-106.29M | $- | $-2.94M | $-389.99M | $- | $- | $-1.96M | $-499.22M | $- | $- | $- | $-2.55M | $- | $-129.83M | $- | $-29.78M |
| Sales Maturities of Investments | $- | $- | $- | $- | $95.66M | $195.42M | $98.92M | $7.73M | $250.15M | $124.87M | $124.98M | $- | $- | $- | $100.00M | $- | $29.98M | $29.78M | $-256.00K | $39.61M |
| Other Investing Activities | $-2.41M | $-4.72M | $-5.15M | $-4.53M | $102.37M | $195.42M | $2.94M | $-7.73M | $-1.96M | $124.87M | $1.96M | $-499.22M | $-2.55M | $- | $100.00M | $-2.55M | $-2.94M | $-100.05M | $-256.00K | $6.89M |
| Net Cash Used for Investing Activities | $-4.13M | $-4.73M | $-5.18M | $-4.61M | $94.34M | $195.36M | $88.87M | $-397.74M | $239.70M | $124.93M | $123.03M | $-499.29M | $-338.00K | $-156.46M | $99.86M | $-2.70M | $29.92M | $-101.01M | $-1.31M | $5.64M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $- | $- | $956.00K | $-2.16M | $896.00K | $- | $- | $-2.09M | $- | $1.93M | $4.04M | $- | $- | $- | $- | $-900.00K | $- | $- | $- |
| Common Stock Repurchased | $-2.00K | $-1.00K | $- | $- | $586.00K | $- | $-585.00K | $-1.00K | $360.00K | $-360.00K | $- | $- | $-1.05M | $-2.36M | $-2.25M | $-9.38M | $-19.15M | $-18.25M | $-163.00K | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $- | $428.00K | $- | $956.00K | $- | $896.00K | $280.00K | $1.56M | $417.00K | $1.86M | $2.22M | $-7.75M | $2.27M | $3.40M | $7.44M | $7.68M | $-140.00K | $168.00K | $136.06M | $12.57M |
| Net Cash Used Provided by Financing Activities | $-2.00K | $427.00K | $- | $956.00K | $-5.76M | $896.00K | $-305.00K | $1.56M | $417.00K | $1.50M | $2.22M | $-7.75M | $1.22M | $1.04M | $5.19M | $-1.70M | $-20.19M | $854.85M | $135.90M | $12.57M |
| Effect of Forex Changes on Cash | $1.24M | $4.40M | $-4.72M | $-31.00K | $-98.00K | $-247.00K | $-471.00K | $-328.00K | $1.77M | $-40.00K | $-1.79M | $-247.00K | $58.00K | $-142.00K | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-16.33M | $-31.47M | $-31.69M | $-63.44M | $52.66M | $158.02M | $48.47M | $-425.66M | $205.94M | $75.41M | $80.25M | $-569.48M | $-43.99M | $-184.78M | $78.81M | $-45.53M | $-14.80M | $723.72M | $108.86M | $-13.89M |
| Cash at End of Period | $229.11M | $245.44M | $276.91M | $308.60M | $372.04M | $320.17M | $162.15M | $113.68M | $539.34M | $333.40M | $257.98M | $177.73M | $747.21M | $791.20M | $975.98M | $897.18M | $942.71M | $957.51M | $233.79M | $124.93M |
| Cash at Beginning of Period | $245.44M | $276.91M | $308.60M | $372.04M | $319.37M | $162.15M | $113.68M | $539.34M | $333.40M | $257.98M | $177.73M | $747.21M | $791.20M | $975.98M | $897.18M | $942.71M | $957.51M | $233.79M | $124.93M | $138.82M |
| Operating Cash Flow | $-13.44M | $-32.35M | $-21.79M | $-59.76M | $-41.58M | $-37.99M | $-39.63M | $-29.15M | $-35.95M | $-50.98M | $-43.21M | $-62.19M | $-44.92M | $-29.22M | $-26.25M | $-41.14M | $-24.53M | $-30.11M | $-25.73M | $-32.09M |
| Capital Expenditure | $-2.42M | $-4.73M | $-5.18M | $-2.89M | $-1.32M | $-60.00K | $-7.10M | $-6.77M | $-10.45M | $56.00K | $10.00K | $-68.00K | $-338.00K | $62.00K | $-135.00K | $-148.00K | $-57.00K | $-957.00K | $-1.05M | $-1.25M |
| Free Cash Flow | $-15.85M | $-37.09M | $-26.97M | $-62.65M | $-42.89M | $-38.05M | $-46.73M | $-35.92M | $-46.39M | $-50.92M | $-43.20M | $-62.26M | $-45.26M | $-29.16M | $-26.39M | $-41.29M | $-24.59M | $-31.07M | $-26.78M | $-33.35M |
American Well Dividends
Explore American Well's dividend history, including dividend yield, payout ratio, and historical payments.
American Well News
Read the latest news about American Well, including recent articles, headlines, and updates.
Amwell® to participate in upcoming investor conferences
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences: On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually. On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference in New York City.
Amwell® to report first quarter 2025 operating results
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m.
Amwell makes inducement grant
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky's employment as Amwell's chief product and technology officer.
Amwell announces innovation leader as chief product and technology officer
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chief product and technology officer, effective today. Zamansky will lead the company's product and R&D organizations.
Amwell® makes grants to new employees under inducement plan
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its Class A common stock to four new employees. The grants were offered as material inducement to the employees' employment with Amwell.
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Stan Berenshteyn - Wells Fargo Securities Jailendra Singh - Truist Securities Eric Percher - Nephron Research Charles Rhyee - TD Cowen Matt Shea - Needham & Company Kevin Caliendo - UBS David Larsen - BTIG Jessica Tassan - Piper Sandler Operator Thank you for standing by and welcome to Amwell's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Amwell® Announces Results for Fourth Quarter and Full Year 2024
BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report.
American Well (AMWL) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of American Well (AMWL) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives Company reiterates guidance for 2024 BOSTON, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a global leader in digital care, today announced it has sold its Amwell Psychiatric Care (APC) business to Avel eCare, a national leading provider of clinician-to-clinician telehealth services. With the divestiture of APC, a virtual psychiatric care service that Amwell purchased in 2019, Amwell continues to sharpen its focus on key growth areas, driving greater efficiencies and fulfilling clients' digital care ambitions.
Amwell CFO Mark Hirschhorn Expands Leadership Role
BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, has announced Chief Financial Officer (CFO) Mark Hirschhorn will take on an expanded role as chief operating officer, effective Jan. 1, 2025. Hirschhorn will now oversee the company's operational and growth strategies, including the clinical, sales and marketing teams, while continuing his responsibilities as CFO.
American Well Corporation (AMWL) Q3 2024 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Ryan MacDonald - Needham & Company Stan Berenshteyn - Wells Fargo Jailendra Singh - Truist Securities Charles Rhyee - TD Cowen Dave Larsen - BTIG Operator Ladies and gentlemen, good afternoon. My name is Abby and I will be your conference operator today.
American Well (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Amwell announces new chief financial officer
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert “Bob” Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell's financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company's strategy to support its long-term growth objectives and enhance shareholder value.
Amwell to report third quarter 2024 operating results
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m.
Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution
BOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Hello Heart, the digital leader in preventive heart health, is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform.
American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for AMWL.